You are here: Industry Insights > GenScript

News List

GenScript Receives "COVID Management Initiative of the Year" in Singapore Business Review Management Excellence Award 2021 prnasia
December 15, 2021
GenScript receives the award on COVID Management Initiative of the Year, Biotechnology industry in the Singapore Business Review (SBR) Management Excellence Award 2021.
GenScript and BioComo Join Forces to Accelerate Novel Intranasal SARS-CoV-2 Vaccine Development in Japan prnasia
December 01, 2021
GenScript Biotech Corporation ("GenScript", Stock Code: 1548.HK), a leading global biotechnology company, and BioComo Incorporation, a drug discovery venture based in Mie prefecture, Japan...
GenScript Announces Notice of Allowance for U.S. Patent Application for SARS-CoV-2 Surrogate Virus Neutralization Kit prnasia
July 29, 2021
GenScript Biotech Corporation announced that the U.S. Patent and Trademark Office (USPTO) has issued a notice of allowance for a patent application covering a novel Surrogate Virus Neutralization Test (sVNT).
GenScript Biotech and Ligand Pharmaceuticals Enter into Global OmniAb® Licensing Agreement prnasia
June 03, 2021
GenScript Biotech Corporation along with its subsidiary, GenScript ProBio, and Ligand Pharmaceuticals Incorporated announced that they have entered into a strategic licensing agreement for Ligand's OmniAb® Platform, a multi-species antibody discovery ...
GenScript ProBio and Neoletix signed a letter of intent on clinical and commercial production of recombinant human coagulation factor VIII prnasia
June 02, 2021
On June 1st 2021, GenScript ProBio and Neoletix (Beijing) Biotechnology Co., Ltd. signed a letter of intent on cooperation for clinical and commercial production of human coagulation factor VIII.
GenScript Launches Research Lentiviral Vector Packaging Service contractpharma
April 30, 2021
GenScript, a leading reagents provider, has launched its Research Lentiviral Vector Packaging Service for cell line development, gene editing, and drug discovery.
GenScript ProBio Enters Collaboration with Singapore's Experimental Drug Development Centre to Develop Anti-Fibrosis Therapeutic Antibody Programme prnasia
April 21, 2021
GenScript Biotech Corporation's biopharmaceutical CDMO segment, GenScript ProBio announced a collaboration with the Experimental Drug Development Centre (EDDC), Singapore's national platform for drug discovery and development, on an anti-fibrosis ...
Molecular Matrix and GenScript Partner to Launch SARS-CoV-2 Neutralizing Antibody Testing Service for Public prnasia
April 14, 2021
Molecular Matrix, Inc. (MMI) and GenScript Biotech Corp. announced that they have partnered to offer GenScript's SARS-CoV-2 neutralizing antibody test to the public via physician screening. GenScript's cPass™ SARS-CoV-2 Neutralization Antibody ...
GenScript, Parkway Laboratories and Diagnostics Development (DxD) Hub collaborate to provide cPass(TM) SARS-CoV-2 Neutralizing Antibody Testing Service in Singapore prnasia
April 12, 2021
GenScript Biotech Corporation, Parkway Laboratories and the Diagnostics Development (DxD) Hub announced their collaboration to provide the cPass™ SARS-CoV-2 neutralizing antibody test in Singapore through Parkway's panel of specialist and GP clinics.
GenScript and G42 Healthcare announce collaboration to provide innovative solutions to fight against COVID-19 prnasia
March 17, 2021
GenScript Biotech Singapore, a subsidiary of GenScript Biotech Corporation, a world leading biotechnology company, and G42 Healthcare, a leading healthcare technology company, based in the UAE, today announced they have signed an agreement to explore ...

Previous page 1 2 3 Next page